GOLDMAN SACHS GROUP INC - IMMUNE PHARMACEUTICALS INC ownership

IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 16 filers reported holding IMMUNE PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$5,000
-28.6%
35,767
-1.3%
0.00%
Q4 2016$7,000
-84.1%
36,225
-76.9%
0.00%
Q3 2016$44,000
+76.0%
156,868
+363.6%
0.00%
Q4 2015$25,000
-28.6%
33,837
+13.4%
0.00%
Q3 2015$35,000
-36.4%
29,848
+5.0%
0.00%
Q2 2015$55,000
-8.3%
28,422
-15.5%
0.00%
Q1 2015$60,000
-3.2%
33,616
+2.7%
0.00%
Q4 2014$62,000
-41.0%
32,745
+5.1%
0.00%
Q3 2014$105,00031,1430.00%
Other shareholders

There were no reported owners of IMMUNE PHARMACEUTICALS INC in Q3 2015.

NameSharesValueWeighting ↓
View complete list of IMMUNE PHARMACEUTICALS INC shareholders